RADON RISK ASSESSMENT IN THE SOUTH DAYI DISTRICT OF THE VOLTA REGION, GHANA: A COMPREHENSIVE INVESTIGATION
Global Multidisciplinary Journal · 2023
DOI: 10.55640/gmj-abc216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Multidisciplinary Journal, 2023. Verfasst von Charles E. Dodor und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This study presents a comprehensive investigation into radon risk assessment in the South Dayi District of the Volta Region, Ghana. Radon, a naturally occurring radioactive gas, poses potential health risks when present in high concentrations, particularly in indoor environments. The research methodology involves measuring radon levels in various residential and commercial buildings across the district using state-of-the-art detection techniques. Additionally, factors such as geological characteristics, building construction materials, and indoor ventilation systems are analyzed to assess their influence on radon concentrations. The findings provide valuable insights into the extent of radon exposure in the South Dayi District and contribute to the development of mitigation strategies to safeguard public health. This study underscores the importance of proactive measures to mitigate radon risks and protect residents in radon-prone regions such as the Volta Region of Ghana.
Zitieren
APA
Dodor, C. E., & Andam, M. B. (2023). RADON RISK ASSESSMENT IN THE SOUTH DAYI DISTRICT OF THE VOLTA REGION, GHANA: A COMPREHENSIVE INVESTIGATION. Global Multidisciplinary Journal. https://doi.org/10.55640/gmj-abc216
Vancouver
Dodor CE, Andam MB. RADON RISK ASSESSMENT IN THE SOUTH DAYI DISTRICT OF THE VOLTA REGION, GHANA: A COMPREHENSIVE INVESTIGATION. Global Multidisciplinary Journal. 2023. doi:10.55640/gmj-abc216
BibTeX
@article{Dodor2023,
author = {Dodor, Charles E. and Andam, Michael B.},
title = {RADON RISK ASSESSMENT IN THE SOUTH DAYI DISTRICT OF THE VOLTA REGION, GHANA: A COMPREHENSIVE INVESTIGATION},
journal = {Global Multidisciplinary Journal},
year = {2023},
doi = {10.55640/gmj-abc216}
}
EUVIMED